Mehr zum Buch
This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.
Buchkauf
Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry, Charles Ralph Buncher, Jia-Yeong Tsay
- Sprache
- Erscheinungsdatum
- 1993
- product-detail.submit-box.info.binding
- (Hardcover),
- Buchzustand
- Beschädigt
- Preis
- 6,30 €inkl. MwSt.
Keiner hat bisher bewertet.
- Titel
- Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry
- Untertitel
- 3rd Edition
- Sprache
- Englisch
- Autor*innen
- Charles Ralph Buncher, Jia-Yeong Tsay
- Verlag
- CRC Press
- Erscheinungsdatum
- 1993
- Einband
- Hardcover
- Seitenzahl
- 592
- ISBN10
- 0824790731
- ISBN13
- 9780824790738
- Reihe
- Schlagwörter
- Sachbücher, Wissenschaft & Mathematik, Mathematik, USA, Technologie, Medizin, Drogen, Apotheke, Medikamente, Arzneimittel, Epidemiologie
- Beschreibung
- This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.